Abstract
On February 6, 2004, the US Food and Drug Administration banned dietary supplements containing ephedrine alkaloids (ephedra) pending Congressional review. The ban culminates a 7-year regulatory process, the first of its kind under the Dietary Supplement Health and Education Act (DSHEA). This paper reviews that process, and the governing rules of DSHEA, within the contexts of modern science and the history of food and drug legislation. The example of ephedra reflects a longstanding conflict between trade and safety and suggests inherent weaknesses within DSHEA that place the public at risk.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
